Structural ensemble-based docking simulation and biophysical studies discovered new inhibitors of Hsp90 N-terminal domain

Abstract

Heat shock protein 90 (Hsp90) is one of the most abundant cellular proteins and plays a substantial role in the folding of client proteins. The inhibition of Hsp90 has been regarded as an attractive therapeutic strategy for treating cancer because many oncogenic kinases are Hsp90 client proteins. In this study, we report new inhibitors that directly bind to N-terminal ATP-binding pocket of Hsp90. Optimized structure-based virtual screening predicted candidate molecules, which was followed by confirmation using biophysical and cell-based assays. Among the reported crystal structures, we chose the two structures that show the most favourable early enrichments of true-positives in the receiver operating characteristic curve. Four molecules showed significant changes in the signals of 2D [1H, 15N] correlation NMR spectroscopy. Differential scanning calorimetry analysis supported the results indicating direct binding. Quantified dissociation constant values of the molecules, determined by a series of 2D NMR experiments, lie in the range of 0.1–33 μM. Growth inhibition assay with breast and lung cancer cells confirmed the cellular activities of the molecules. Cheminformatics revealed that the molecules share limited chemical similarities with known inhibitors. Molecular dynamics simulations detailed the putative binding modes of the inhibitors.

Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A

“…To identify a direct protein target of SFX in cancer cells, we applied an in silico approach based on a Similarity Ensemble Approach (SEA), a method developed by our group 29 . Using data from the BindingDB, SEA identified four proteins (Fig.…”

Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors

“…Such false-positives might be a result of conformational changes in the ChE enzymes upon binding of ligands and the case-dependent performances of docking algorithms in prioritizing true-positives. 61 Further, receptor plasticity also plays a significant role in false-positive docking results. 62 Interestingly, a study conducted by Pahl et al reported that compounds that showed higher docking scores were found to have zero inhibitory action.…”

Discovery of small molecule inhibitors against the NS3/4A serine protease of Hepatitis C virus genotype 3 via highthroughput virtual screening and in vitro evaluations

“…In spite of the numerous benefits associated with structure-based virtual screening, there are a few drawbacks that may arise such as false-positive results. Kim et al (2018) suggested that these may occur as a result of conformational changes of the receptor through ligand binding and also via docking algorithm preferences in selecting true-positives, which may require evaluation on a case-by-case basis. One way to prevent false positives is to conduct in vitro experiments, as both docking and ADME/T predictions do not warrant efficiency of the compounds.…”